Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Division win Oxford Sparks competition to have an animation created about research into Alzheimer's disease.

Before Christmas 2017, Oxford Sparks ran a competition which offered research groups the chance to win an animation about their research. The competition was won by members of the Alzheimer’s Research UK Oxford Drug Discovery Institute – Dr Hazel Hall-Roberts, a neuroimmunology cell biologist, and Keely Jones, the research group administrator – who will receive a bespoke animation to illustrate and explain their research. Alzheimer’s Research UK Oxford Drug Discovery Institute is based within the Nuffield Department of Clinical Medicine. 

The animation will explain the complex elements of Alzheimer's research, and highlight the importance of developing new drugs to treat the disease. The researchers will collaborate with professional animators to produce this short video about their research, and receive a dedicated social media campaign to publicise it. 

The other winner of the competition was Brooke Johnson, who is based in the Department of Earth Sciences in MPLS. 

Oxford Sparks is a public-facing online project that aims to bring alive the University's science research for wider audiences. Through a diverse range of digital content and activities they showcase and explain research, and encourage the public to engage with scientific research. They have already developed several animations with Medical Sciences researchers, and you can see some examples on their website

Find out more (MPLS news item)

 

 

Similar stories

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

New study shows overwhelming public support for donating vaccines to low-income countries

Coronavirus COVID-19 General Research

A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.